Microneedling in androgenetic alopecia
Not Applicable
- Conditions
- Androgenetic alopecia.Androgenic alopecia
- Registration Number
- IRCT20191203045592N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients with moderate to severe androgenetic alopecia
Patients who have not used systemic medications that influence hair growth within the past 6 months
Exclusion Criteria
Patients with other forms of alopecia, such as telogen effluvium and alopecia areata
Patients with history of bleeding disorders
Patients with keloidal tendency
Patients with active infection at the microneedling site
Patients with skin dermatosis with risk of Koebner phenomenon, such as psoriasis and lichen planus
Pregnant and lactating women
Patients with any major systemic disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hail count. Timepoint: At start of study and 14 weeks. Method of measurement: Scalp & Hair Polarizing HMS System (KC Technology Company; Korea).;Hair thickness. Timepoint: At start of study and 14 weeks. Method of measurement: Scalp & Hair Polarizing HMS System (KC Technology Company; Korea).;Patient's satisfaction score. Timepoint: At 14 weeks. Method of measurement: The standardized 7 point rating scale (–3 = greatly decreased, –2 = moderately decreased, –1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).;Investigator's assessment based on changes in standard photographs. Timepoint: Standard photography at base line and at 14 weeks. Method of measurement: The standardized 7 point rating scale (–3 = greatly decreased, –2 = moderately decreased, –1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).
- Secondary Outcome Measures
Name Time Method